Position in JNJ
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$7,764,624
+$417,980 QoQ
Shares Held
30,573
+1.7% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
1.22%
of 13F equity value
Holder Rank
#1,269
of 4,664 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026CAMBIENT FAMILY OFFICE, LLC holds $51,359,335 across 9 Drug Manufacturers - General names. JNJ ranks #3 (15.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
24,259 | $29,096,974 | |
| 2 | ABBV |
AbbVie Inc.
|
36,055 | $9,072,880 | |
| 3 | JNJ |
Johnson & Johnson
This page
|
30,573 | $7,764,624 | |
| 4 | MRK |
Merck & Co., Inc.
|
12,738 | $1,636,833 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
9,715 | $1,227,393 | |
| 6 | AMGN |
Amgen Inc
|
2,796 | $1,012,487 | |
| 7 | NVS |
Novartis AG
|
4,264 | $668,254 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
8,131 | $468,508 |
All Filings in JNJ
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,764,624 | 30,573 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $7,346,644 | 30,055 | Shares | Sole | 2026-04-21 | |
| 2025-12-31 | $5,847,579 | 28,256 | Shares | Sole | 2026-02-20 | |
| No filing history on record for this holder in this stock. | ||||||